A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.
Experimental Treatment Gaining Traction Via Social Media
Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are encouraged to contact these profiles privately for source information, while also obtaining promotional offers.
Thriving Trade on Social Networks
Separately, a flourishing trade exists on messaging services, where groups with numerous of members share “before and after” images, injection guides and assertions of rapid UK delivery. Vendors market the substance there before directing buyers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Healthcare Experts Express Concerns
However, doctors and chemists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals injecting products of unknown origin.
Some experts stated the popularity for the experimental drug could be connected to the rising cost of licensed slimming products such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be marketed or supplied for human use under the British medical regulations.
Some influencers try to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach pharmaceutical, advertising, and customer laws, risking fines, legal action or prison.
Service Reaction and Content Removal
According to TikTok, the service has taken down problematic content and banned related hashtags and query recommendations. The company said it was dedicated to keeping the platform safe and allocating resources in enhancing enforcement strategies.
Digital Trading Operations
Research also discovered communities with up to 9,000 members marketing retatrutide using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, filled with photos of slimming results, glowing testimonials and step-by-step guides for mixing or injecting at home.
After moments of joining one group, a vendor shared WhatsApp details, where most transactions take place. The seller provided an instruction manual and promised delivery within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about weight, health issues or past usage.
Product Details and Pricing
Inside these communities, messages show black plastic parcels with Royal Mail labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When asked how much time a injector should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for the messaging service said it actively monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting materials they can’t verify. Even if the science behind this drug is valid, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the surge in interest to current price rises for authorized slimming medications such as Mounjaro. “With prices rising, patients are using social media. But counterfeit injections are highly risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.
Her staff has already seen patients injured by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”
Producer Position
A representative from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company investigational product not yet approved … may expose patients to potentially significant health risks”.
